跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 11,768 条关于
“TCG Crossover”
全部
11,768
临床试验
10,530
药物
755
机构
23
资讯
460
10个月前
Liquidia's YUTREPIA Achieves Commercial Success with $51.7M Q3 Sales, Attracting Major Biotech Fund Investment
4年前
Arbor Biotechnologies Secures $215M Series B to Advance CRISPR Gene Editing Platform
4个月前
Abivax Repurchases $90 Million in Royalty Certificates, Streamlining Capital Structure Ahead of Obefazimod Commercialization
4个月前
Accro Bioscience Secures $50M Series C to Advance RIPK2 Inhibitor AC-101 for Ulcerative Colitis
去年
Indena and TCG GreenChem Form Strategic Alliance to Accelerate ADC Payload-Linker Development
去年
TCG Labs Soleil Raises $400M to Build Single-Asset Biotech Startups for Strategic Partnerships
去年
Long-Term Follow-Up of TRANSFORM Trial Shows Sustained Benefits of Liso-Cel CAR T-Cell Therapy in Relapsed LBCL
2个月前
TriMaster Crossover Trial Shows Routine Clinical Data May Outperform Diabetes Subtypes for Precision Prescribing
去年
Juri Biosciences Secures Global Rights to KLK2-Targeted T-Cell Engager for Metastatic Prostate Cancer in $210M Deal
2年前
Eli Lilly's Lutetium Zadavotide Guraxetan Shows Promise in Metastatic Castration-Resistant Prostate Cancer
第 1 页,共 46 页
上一页
下一页